These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1188 related articles for article (PubMed ID: 17493088)

  • 1. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
    Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
    Larsen MT; Lyngborg K; Pedersen F; Corell P
    Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B; Opolski G
    Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of atrial fibrillation recurrence rates after successful electrical cardioversion in patients with hyperthyroidism-induced versus non-hyperthyroidism-induced persistent atrial fibrillation.
    Siu CW; Jim MH; Zhang X; Chan YH; Pong V; Kwok J; Kung AW; Lau CP; Tse HF
    Am J Cardiol; 2009 Feb; 103(4):540-3. PubMed ID: 19195517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
    Roijer A; Eskilsson J; Olsson B
    Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
    Kapoor A; Kumar S; Singh RK; Pandey CM; Sinha N
    J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up.
    Gasparini G; Bonso A; Themistoclakis S; Giada F; Raviele A
    Europace; 2001 Apr; 3(2):90-5. PubMed ID: 11333060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation requiring urgent medical care. Approach and outcome in the various departments of admission. Data from the atrial Fibrillation/flutter Italian REgistry (FIRE).
    Santini M; De Ferrari GM; Pandozi C; Alboni P; Capucci A; Disertori M; Gaita F; Lombardi F; Maggioni AP; Mugelli A; Salerno-Uriarte JA; Sermasi S; Schwartz PJ;
    Ital Heart J; 2004 Mar; 5(3):205-13. PubMed ID: 15119503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion.
    Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transesophageal cardioversion of atrial flutter and atrial fibrillation using an electric balloon electrode system.
    Zheng F; Qi X; Liu H; Kang N
    Chin Med J (Engl); 2003 Sep; 116(9):1325-8. PubMed ID: 14527358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
    Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
    Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the rectilinear biphasic waveform with the monophasic damped sine waveform for external cardioversion of atrial fibrillation and flutter.
    Niebauer MJ; Brewer JE; Chung MK; Tchou PJ
    Am J Cardiol; 2004 Jun; 93(12):1495-9. PubMed ID: 15194019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.
    Stiell IG; Macle L;
    Can J Cardiol; 2011; 27(1):38-46. PubMed ID: 21329861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Janion M
    Kardiol Pol; 2003 Apr; 58(4):255-63. PubMed ID: 14517556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B; Straumann E; Bertel O
    Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.